US6143506AExpiredUtility
Diagnostic method for detection of periodontitis or peri-implantitis
Assignee: RES FOUNDATION OF STATE OF NYPriority: Aug 13, 1998Filed: Aug 13, 1998Granted: Nov 7, 2000
Est. expiryAug 13, 2018(expired)· nominal 20-yr term from priority
G01N 33/573G01N 2333/96486Y10S435/975
71
PatentIndex Score
35
Cited by
8
References
8
Claims
Abstract
The invention relates to methods and test kits for diagnosis of periodontal disease activity in mammals, especially in human. The methods of the invention provide for rapid chair-side diagnosis of periodontitis, peri-implantitis and HIV (+)-infection/AIDS-disease related periodontal diseases. Especially, the methods of the invention provide for rapid chair-side diagnosis of the loss of bone density associated with periodontal diseases.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1. A method for monitoring the course and treatment of periodontal disease or peri-implantitis wherein the detection comprises the steps of: (a) collecting a gingival crevicular fluid, peri-implant sucular fluid, saliva or mouthrinse sample; (b) contacting said sample with at least one molecule which recognizes mammalian matrix metalloproteinase-13 in said sample; and (c) detecting the presence of said mammalian matrix metalloproteinase-13, wherein an increased level of MMP-13 indicates periodontal disease or peri-implantitis.
2. The method of claim 1, wherein at least one of the one molecules recognizing MMP-13 is an antibody.
3. The method of claim 2, wherein the antibody is a monoclonal antibody.
4. The method of claim 2, wherein the antibody is a polyclonal antibody.
5. The method of claim 2, wherein the antibody is a fragment of a monclonal or polyclonal antibody.
6. The method of claim 1, wherein the molecule that recognizes MMP-13 is labeled with a label selected from the group consisting of direct and indirect labels.
7. The method of claim 1, wherein said mammalian matrix metalloproteinase-13 is a human matrix metalloproteinase-13.
8. The method of claim 1, which additionally comprises a molecule which recognizes mammalian matrix metalloproteinase-8 (MMP-8).Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.